Capstone Therapeutics (CAPS) Revenue & Revenue Breakdown
Capstone Therapeutics Revenue Highlights
Latest Revenue (Y)
$44.88M
Latest Revenue (Q)
$7.90M
Capstone Therapeutics Revenue by Period
Capstone Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $44.88M | -7.19% |
| 2023-12-31 | $48.35M | -21.45% |
| 2022-12-31 | $61.56M | -7.76% |
| 2021-12-31 | $66.74M | 46.85% |
| 2020-12-31 | $45.45M | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | - |
Capstone Therapeutics generated $44.88M in revenue during NA 2024, up -7.19% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Capstone Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $7.90M | -23.41% |
| 2024-12-31 | $10.31M | -16.28% |
| 2024-09-30 | $12.32M | -4.41% |
| 2024-06-30 | $12.89M | 37.69% |
| 2024-03-31 | $9.36M | -1.33% |
| 2023-12-31 | $9.48M | -21.48% |
| 2023-09-30 | $12.08M | -20.38% |
| 2023-06-30 | $15.17M | 30.55% |
| 2023-03-31 | $11.62M | 5.49% |
| 2022-12-31 | $11.02M | -37.84% |
| 2022-09-30 | $17.72M | -9.18% |
| 2022-06-30 | $19.51M | 46.53% |
| 2022-03-31 | $13.31M | -3.35% |
| 2021-12-31 | $13.78M | -33.35% |
| 2021-09-30 | $20.67M | 0.91% |
| 2021-06-30 | $20.48M | 73.40% |
| 2021-03-31 | $11.81M | -14.15% |
| 2020-12-31 | $13.76M | -22.36% |
| 2020-09-30 | $17.72M | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | -100.00% |
| 2018-06-30 | $2.00M | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | - |
Capstone Therapeutics generated $7.90M in revenue during Q1 2025, up -23.41% compared to the previous quarter, and up 83.28% compared to the same period a year ago.